Dr Garwin Kim Sing is currently an Associate Professor in Immunology and Microbiology at Alfaisal University. His B.Sc. in Microbiology, Biochemistry and Molecular Biology was awarded at the University of Cape Town, South Africa. He subsequently did a BSc(Hons) and PhD in Viral Immunopathology at the University of the Witwatersrand, South Africa. In 1984 he was awarded a prestigious Fogarty Fellowship to do his postdoctoral training at the National Cancer Institute in Maryland, USA. After 4 years, he then took up a position as a Senior Research Officer at the Queensland Institute for Medical Research in Brisbane, Australia. He subsequently moved to the University of Edinburgh in the United Kingdom where he spent eight years at the Division of Pathway Medicine before joining Alfaisal University. Dr Kim Sing also holds a postgraduate diploma in teaching, which was attained at the Queensland University of Technology in Brisbane, Australia in 2010. He has published extensively in many areas of Virology and Immunology, and has worked on a diverse array of viral diseases including Influenza, Cytomegalovirus, Human Immunodeficiency Virus and Hepatitis B Virus. His current interests are on the antibacterial effects of graphene carbon nanoparticles.

The immunopathology of acute and chronic virus - host interactions (cytomegalovirus, hepatitis B virus, human immunodeficiency virus) in the context of cytokine production, cytotoxic and regulatory T lymphocytes and macrophages.